503 related articles for article (PubMed ID: 35536759)
61. Teriflunomide promotes oligodendroglial differentiation and myelination.
Göttle P; Manousi A; Kremer D; Reiche L; Hartung HP; Küry P
J Neuroinflammation; 2018 Mar; 15(1):76. PubMed ID: 29534752
[TBL] [Abstract][Full Text] [Related]
62. Histamine Receptor 3 negatively regulates oligodendrocyte differentiation and remyelination.
Chen Y; Zhen W; Guo T; Zhao Y; Liu A; Rubio JP; Krull D; Richardson JC; Lu H; Wang R
PLoS One; 2017; 12(12):e0189380. PubMed ID: 29253893
[TBL] [Abstract][Full Text] [Related]
63. Inactivation of Protein Tyrosine Phosphatase Receptor Type Z by Pleiotrophin Promotes Remyelination through Activation of Differentiation of Oligodendrocyte Precursor Cells.
Kuboyama K; Fujikawa A; Suzuki R; Noda M
J Neurosci; 2015 Sep; 35(35):12162-71. PubMed ID: 26338327
[TBL] [Abstract][Full Text] [Related]
64. miR-219 Cooperates with miR-338 in Myelination and Promotes Myelin Repair in the CNS.
Wang H; Moyano AL; Ma Z; Deng Y; Lin Y; Zhao C; Zhang L; Jiang M; He X; Ma Z; Lu F; Xin M; Zhou W; Yoon SO; Bongarzone ER; Lu QR
Dev Cell; 2017 Mar; 40(6):566-582.e5. PubMed ID: 28350989
[TBL] [Abstract][Full Text] [Related]
65. Revisiting Notch in remyelination of multiple sclerosis lesions.
Brosnan CF; John GR
J Clin Invest; 2009 Jan; 119(1):10-3. PubMed ID: 19104146
[TBL] [Abstract][Full Text] [Related]
66. Oligodendrocyte-lineage cell exocytosis and L-type prostaglandin D synthase promote oligodendrocyte development and myelination.
Pan L; Trimarco A; Zhang AJ; Fujimori K; Urade Y; Sun LO; Taveggia C; Zhang Y
Elife; 2023 Feb; 12():. PubMed ID: 36779701
[TBL] [Abstract][Full Text] [Related]
67. Clemastine and metformin extend the window of NMDA receptor surface expression in ageing oligodendrocyte precursor cells.
Kamen Y; Evans KA; Sitnikov S; Spitzer SO; de Faria O; Yucel M; Káradóttir RT
Sci Rep; 2024 Feb; 14(1):4091. PubMed ID: 38374232
[TBL] [Abstract][Full Text] [Related]
68. Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis.
Motavaf M; Sadeghizadeh M; Javan M
Cell Mol Neurobiol; 2017 Nov; 37(8):1335-1348. PubMed ID: 28224237
[TBL] [Abstract][Full Text] [Related]
69. Nuclear receptors and differentiation of oligodendrocyte precursor cells.
Baldassarro VA; Flagelli A; Sannia M; Calzà L
Vitam Horm; 2021; 116():389-407. PubMed ID: 33752826
[TBL] [Abstract][Full Text] [Related]
70. Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis.
Wolswijk G
Brain; 2000 Jan; 123 ( Pt 1)():105-15. PubMed ID: 10611125
[TBL] [Abstract][Full Text] [Related]
71. Knockdown of Lingo1b protein promotes myelination and oligodendrocyte differentiation in zebrafish.
Yin W; Hu B
Exp Neurol; 2014 Jan; 251():72-83. PubMed ID: 24262204
[TBL] [Abstract][Full Text] [Related]
72. A Role of Microtubules in Oligodendrocyte Differentiation.
Lee BY; Hur EM
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033476
[TBL] [Abstract][Full Text] [Related]
73. Tissue transglutaminase activity is involved in the differentiation of oligodendrocyte precursor cells into myelin-forming oligodendrocytes during CNS remyelination.
Van Strien ME; Baron W; Bakker EN; Bauer J; Bol JG; Brevé JJ; Binnekade R; Van Der Laarse WJ; Drukarch B; Van Dam AM
Glia; 2011 Nov; 59(11):1622-34. PubMed ID: 21818782
[TBL] [Abstract][Full Text] [Related]
74. Regulation of oligodendrocyte precursor migration during development, in adulthood and in pathology.
de Castro F; Bribián A; Ortega MC
Cell Mol Life Sci; 2013 Nov; 70(22):4355-68. PubMed ID: 23689590
[TBL] [Abstract][Full Text] [Related]
75. Lesion stage-dependent causes for impaired remyelination in MS.
Heß K; Starost L; Kieran NW; Thomas C; Vincenten MCJ; Antel J; Martino G; Huitinga I; Healy L; Kuhlmann T
Acta Neuropathol; 2020 Sep; 140(3):359-375. PubMed ID: 32710244
[TBL] [Abstract][Full Text] [Related]
76. Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelination.
Mi S; Lee X; Hu Y; Ji B; Shao Z; Yang W; Huang G; Walus L; Rhodes K; Gong BJ; Miller RH; Pepinsky RB
Nat Med; 2011 Jul; 17(7):816-21. PubMed ID: 21725297
[TBL] [Abstract][Full Text] [Related]
77. Factors that retard remyelination in multiple sclerosis with a focus on TIP30: a novel therapeutic target.
Nakahara J; Aiso S; Suzuki N
Expert Opin Ther Targets; 2009 Dec; 13(12):1375-86. PubMed ID: 19839715
[TBL] [Abstract][Full Text] [Related]
78. Regulators of Oligodendrocyte Differentiation.
Emery B; Wood TL
Cold Spring Harb Perspect Biol; 2024 Jun; 16(6):. PubMed ID: 38503504
[TBL] [Abstract][Full Text] [Related]
79. Transplanted miR-219-overexpressing oligodendrocyte precursor cells promoted remyelination and improved functional recovery in a chronic demyelinated model.
Fan HB; Chen LX; Qu XB; Ren CL; Wu XX; Dong FX; Zhang BL; Gao DS; Yao RQ
Sci Rep; 2017 Feb; 7():41407. PubMed ID: 28145507
[TBL] [Abstract][Full Text] [Related]
80. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.
Reynolds R; Dawson M; Papadopoulos D; Polito A; Di Bello IC; Pham-Dinh D; Levine J
J Neurocytol; 2002; 31(6-7):523-36. PubMed ID: 14501221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
